7Baggers

Broadridge Financial Solutions Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 
 Stock-Based Compensation  
 Capital Expenditure  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 -22.8-16.31-9.83-3.343.149.6316.1122.6Milllion

Broadridge Financial Solutions Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 
                                                          
  cash flows from operating activities                                                        
  net earnings374,200,000 243,100,000 142,400,000 79,800,000 323,200,000 213,700,000 70,300,000 90,900,000 324,100,000 198,500,000 57,600,000 50,400,000 248,100,000 176,600,000 47,200,000 67,200,000 260,400,000 165,000,000 56,300,000 65,800,000 229,700,000 166,800,000 10,100,000 55,900,000 183,300,000 172,200,000 49,900,000 76,700,000 206,800,000 109,100,000 62,100,000 49,900,000 187,100,000 75,900,000 30,100,000 33,700,000 170,100,000 63,600,000 40,300,000 33,500,000 165,900,000 54,000,000 34,700,000 32,500,000 140,200,000 50,800,000 27,600,000 44,400,000 134,600,000 43,400,000 15,800,000 18,300,000 83,400,000 16,700,000 6,800,000 16,700,000 
  adjustments to reconcile net earnings to net cash flows from operating activities:                                                        
  depreciation and amortization33,100,000 32,500,000 32,800,000 32,300,000 30,200,000 30,500,000 29,700,000 29,400,000 20,700,000 21,200,000 21,800,000 20,700,000 20,000,000 21,300,000 20,700,000 20,400,000 19,800,000 16,300,000 15,900,000 15,400,000 17,300,000 15,100,000 20,900,000 20,500,000 21,500,000 21,200,000 21,300,000 21,200,000 21,400,000 20,700,000 20,600,000 19,400,000 17,400,000 16,700,000 17,000,000 17,500,000 13,400,000 13,400,000 13,400,000 12,400,000 12,800,000 12,500,000 12,000,000 12,000,000 12,100,000 12,500,000 11,300,000 10,900,000 10,700,000 10,900,000 12,500,000 13,500,000 13,700,000 13,600,000 12,500,000 11,200,000 
  amortization of acquired intangibles and purchased intellectual property50,000,000 48,900,000 49,500,000 48,200,000 48,900,000 50,700,000 49,900,000 50,800,000 51,600,000 53,300,000 53,600,000 55,900,000 58,200,000 60,800,000 62,500,000 68,700,000 56,900,000 31,900,000 32,600,000 32,300,000 32,000,000 32,500,000 30,300,000 28,100,000 23,100,000 21,100,000 21,300,000 21,900,000 22,000,000 20,200,000 19,800,000 19,400,000 19,800,000 19,700,000 20,300,000 12,800,000                     
  amortization of other assets42,800,000 42,100,000 43,100,000 42,800,000 41,000,000 39,100,000 38,400,000 39,300,000 30,900,000 31,200,000 32,000,000 32,100,000 33,800,000 31,300,000 35,400,000 30,900,000 30,500,000 30,200,000 26,600,000 26,300,000 26,600,000 26,300,000 26,900,000 22,800,000 20,600,000 22,200,000 23,000,000 21,600,000 13,000,000 12,600,000 11,800,000 11,100,000 9,000,000 7,700,000 7,800,000 7,400,000 7,100,000 7,000,000 6,000,000 6,500,000 6,600,000 7,800,000 7,800,000 7,500,000 7,500,000 7,200,000 6,700,000 6,600,000 6,400,000 6,300,000 5,800,000 5,500,000 5,300,000 4,700,000 4,500,000 4,300,000 
  write-down of long lived assets and related charges                                                        
  stock-based compensation expense16,000,000 20,800,000 21,700,000 14,900,000 13,500,000 20,200,000 20,500,000 16,400,000 15,700,000 20,900,000 20,900,000 15,600,000 13,600,000 18,600,000 22,600,000 13,600,000 12,200,000 17,700,000 18,300,000 10,400,000 13,200,000 17,300,000 18,500,000 11,800,000 11,600,000 17,400,000 18,700,000 10,700,000 15,900,000 14,500,000 16,200,000 8,500,000 11,400,000 11,900,000 14,000,000 8,800,000 8,600,000 12,300,000 13,200,000 9,000,000 8,700,000 10,300,000 11,200,000 8,400,000 9,600,000 10,300,000 9,900,000 4,800,000 6,000,000 8,200,000 8,400,000 4,500,000 6,700,000 7,800,000 8,300,000 5,500,000 
  deferred income taxes32,300,000 -5,300,000 -14,900,000 -17,300,000 -56,800,000 -23,700,000 -41,400,000 2,200,000 -1,300,000 -14,200,000 -25,600,000 -9,700,000 3,000,000 31,300,000 19,400,000 -3,000,000 27,800,000 13,300,000 6,200,000 4,700,000 19,300,000 10,500,000 -8,300,000 7,500,000 -20,900,000 27,400,000 -8,600,000 -1,400,000 12,200,000 -10,300,000 -6,100,000 -5,100,000 1,400,000 -7,200,000 -1,100,000 -7,800,000 14,700,000 -6,800,000 -5,000,000 -8,800,000 29,300,000 -17,300,000 -6,200,000 -5,200,000 3,700,000 -12,100,000 -3,600,000 400,000 15,400,000 7,200,000 -3,500,000 -5,000,000 8,600,000 -2,100,000 -10,500,000 -4,400,000 
  other-12,400,000 1,000,000 -5,400,000 -7,600,000 -28,200,000 -5,600,000 -8,600,000 -15,300,000 -10,900,000 -12,800,000 -7,200,000 3,500,000 -100,000 1,500,000 -20,200,000 900,000 4,800,000 -7,500,000 -12,900,000 -16,100,000 -10,900,000 -3,100,000 -1,900,000 -11,000,000 -10,400,000 -13,800,000 -8,000,000 -5,400,000 -6,000,000 -13,500,000 400,000 -2,100,000 900,000 -5,700,000 3,000,000 2,300,000 -6,200,000 -2,700,000 5,400,000 -1,100,000 4,000,000 4,000,000 800,000 -3,900,000 5,100,000 3,800,000 -2,300,000 5,000,000 2,000,000 -700,000 5,100,000 5,900,000 -1,300,000 -500,000 -1,100,000 
  changes in operating assets and liabilities, net of assets and liabilities acquired:                                                        
  accounts receivable121,300,000 -131,400,000 -137,900,000 179,800,000 108,500,000 -252,500,000 38,200,000 68,400,000                                                 
  other current assets-12,600,000 13,400,000 -14,900,000 8,700,000 -8,900,000 29,700,000 -15,000,000 -8,600,000                                                 
  payables and accrued expenses74,000,000 125,800,000 107,400,000 -453,700,000 289,700,000 108,000,000 33,000,000 -294,200,000                                                 
  contract liabilities16,700,000 21,800,000 39,800,000 -21,800,000 50,000,000 35,600,000 13,400,000 -18,400,000                                                 
  other non-current assets-39,700,000 -48,100,000 -31,700,000 -28,700,000 -56,700,000 -79,000,000 -57,900,000 -38,800,000                                                 
  other non-current liabilities-7,300,000 -5,200,000 2,700,000 -3,000,000 -36,500,000 33,300,000 17,100,000 10,400,000                                                 
  net cash flows from operating activities699,700,000 360,400,000 236,700,000 -125,500,000 721,000,000 207,400,000 189,800,000 -62,000,000 729,200,000    457,400,000 80,700,000   450,600,000 106,200,000   442,600,000 144,100,000   399,100,000 135,800,000   418,800,000 133,000,000   353,800,000 167,600,000   276,600,000 118,500,000 67,200,000 -24,600,000 274,800,000 85,800,000 53,700,000 17,100,000  96,500,000           
  cash flows from investing activities                                                        
  capital expenditures-15,600,000 -11,500,000 -8,800,000 -7,900,000 -17,800,000 -22,800,000 -12,100,000 -4,700,000 -17,000,000 -5,500,000 -10,400,000 -5,500,000 -7,100,000 -10,600,000 -5,600,000 -5,700,000 -10,400,000 -11,400,000 -15,800,000 -14,300,000 -14,200,000 -16,900,000 -17,500,000 -14,100,000 -19,700,000 -9,900,000 -12,300,000 -8,700,000 -21,900,000 -12,700,000 -12,400,000 -29,700,000 -33,700,000 -31,800,000 -12,700,000 -7,200,000 -14,600,000 -14,400,000 -13,800,000 -14,900,000 -27,400,000 -9,000,000 -7,900,000 -6,000,000 -7,500,000 -9,100,000 -13,200,000 -10,500,000 -8,500,000 -13,200,000 -10,100,000 -6,400,000 -11,000,000 -9,200,000 -9,500,000 -4,100,000 
  free cash flows                                                        
  software purchases and capitalized internal use software-20,800,000 -12,100,000 -14,000,000 -24,200,000 -18,600,000 -17,400,000 -9,900,000 -9,700,000 -11,400,000 -8,200,000 -9,100,000 -8,100,000 -11,600,000 -14,600,000 -7,700,000 -10,200,000 -19,100,000 -9,000,000 -11,000,000 -9,700,000 -11,000,000 -13,600,000 -5,200,000 -6,200,000 -6,500,000 -6,200,000 -2,500,000 -6,800,000 -5,300,000 -5,500,000 -4,100,000 -6,300,000 -10,500,000 -5,700,000 -4,500,000 -7,600,000 -4,800,000 -4,800,000 -5,300,000 -2,900,000                 
  acquisitions, net of cash acquired-185,500,000 -8,000,000         -13,300,000     -69,500,000 -221,500,000 -48,100,000     -45,300,000 -32,800,000 -26,500,000 -3,700,000 -600,000 -19,700,000 -26,400,000 -402,000,000 -37,600,000 -2,100,000   -138,000,000 -33,300,000   200,000 -59,400,000 -37,700,000     -100,000 400,000 -72,700,000 
  other investing activities-3,600,000 -2,200,000       -3,000,000 -300,000   -10,800,000 -1,800,000 -4,300,000 -7,100,000 -22,200,000 -800,000 -8,300,000 -2,700,000 11,500,000 3,400,000 -800,000 -17,900,000 -3,500,000 -1,000,000 -1,000,000 -800,000                           
  net cash flows from investing activities-40,100,000 -25,700,000 -210,300,000 -40,100,000 -71,400,000 -40,200,000 -22,000,000 -14,400,000                                                 
  cash flows from financing activities                                                        
  debt proceeds317,800,000 180,000,000 270,300,000 470,000,000 300,000,000 100,000,000 160,000,000 462,700,000 240,000,000 170,000,000 170,000,000 410,000,000 70,000,000 120,000,000 100,000,000 380,000,000 3,600,000,000 65,000,000 130,000,000 530,000,000 46,600,000 349,200,000 888,600,000 337,500,000 433,100,000 160,000,000 90,000,000 120,000,000                             
  debt repayments-505,200,000 -400,000,000 -197,300,000 -240,000,000 -460,000,000 -240,000,000 -190,000,000 -192,700,000 -905,000,000 -200,000,000 -130,000,000 -140,000,000 -445,000,000 -109,500,000 -111,000,000 -100,000,000 -1,450,100,000 -92,800,000 -137,800,000 -550,000,000 -332,200,000 -118,800,000 -801,800,000 -40,000,000 -137,400,000 -180,000,000 -40,000,000 -30,000,000                             
  dividends paid-103,100,000 -103,000,000 -102,800,000 -93,400,000 -94,300,000 -94,200,000 -94,100,000 -85,600,000 -85,300,000 -85,400,000 -85,300,000 -75,000,000 -74,800,000 -74,700,000 -74,400,000 -66,800,000 -66,600,000 -66,600,000 -66,300,000 -62,200,000 -61,800,000 -62,000,000 -61,800,000 -55,400,000 -56,100,000 -56,100,000 -56,500,000 -42,500,000 -42,800,000 -42,600,000 -42,500,000 -37,900,000 -38,600,000 -39,600,000 -38,500,000 -35,500,000 -35,200,000 -35,600,000 -35,400,000 -32,000,000 -32,200,000 -32,500,000 -32,400,000 -25,200,000 -25,200,000 -25,000,000 -25,000,000 -21,500,000 -21,600,000 -21,900,000 -22,000,000 -20,300,000 -19,900,000 -100,000 -39,600,000 -18,500,000 
  purchases of treasury stock-130,700,000 -300,000 -3,600,000 -300,000 -323,600,000 -300,000 -400,000 -161,100,000 -20,600,000 -1,200,000 -400,000 -2,100,000 -20,700,000 -400,000   -20,500,000 -200,000 -800,000 -18,800,000    -277,500,000 -119,200,000 -1,100,000 -247,300,000 -26,800,000 -700,000 -2,300,000 -130,200,000 -111,400,000 -61,200,000 -40,000,000 -22,800,000 -86,400,000 -7,600,000 -3,000,000 -145,700,000 -130,900,000 -10,000,000 -15,100,000 -95,700,000 -20,600,000 -5,500,000 -7,900,000 -99,800,000 -46,000,000 -16,600,000 -76,100,000 -15,800,000 -15,100,000 -10,900,000 -9,800,000 
  proceeds from exercise of stock options10,700,000 21,000,000 12,800,000 17,800,000 1,900,000 25,700,000 7,100,000 37,700,000 8,000,000 2,900,000 2,000,000 30,200,000 9,800,000 9,900,000 31,800,000 8,700,000 1,400,000 6,300,000 6,500,000 21,100,000 15,400,000 4,800,000 3,100,000 18,500,000 7,500,000 4,500,000 11,500,000 7,600,000 13,900,000 33,700,000 2,600,000 1,800,000 15,500,000 11,400,000 -7,400,000 41,400,000 3,800,000 10,000,000 7,900,000 3,100,000 11,800,000 20,700,000 14,200,000 15,400,000 16,300,000 21,500,000 5,800,000 5,900,000 18,900,000 9,800,000 7,800,000 9,800,000 6,500,000 17,600,000 12,200,000 7,300,000 
  other financing activities-12,900,000 -2,800,000 -3,600,000 -2,300,000 -4,300,000 -200,000 -6,100,000 -3,700,000 -15,000,000 -2,200,000 -300,000 -13,800,000 -700,000 -2,600,000 -4,900,000 -11,300,000 -10,100,000 -16,300,000 -10,900,000 400,000 -1,500,000 -5,800,000 -2,500,000 -3,700,000 -5,300,000 -1,900,000 100,000 -3,500,000 -5,500,000                         
  net cash flows from financing activities-423,300,000 -305,200,000 -24,100,000 151,800,000 -580,400,000 -208,900,000 -123,500,000 57,300,000 -778,000,000 -113,600,000 -45,900,000 222,800,000 -474,400,000 -55,600,000 -57,800,000 217,000,000 2,052,900,000 -98,500,000 -83,900,000 -72,700,000 -350,400,000 121,100,000 22,400,000 258,100,000   -116,100,000 54,200,000   -110,700,000 146,100,000   -25,900,000 96,100,000   -11,200,000 13,700,000                 
  effect of exchange rate changes on cash and cash equivalents8,000,000 -2,200,000 -5,100,000 2,100,000 -400,000 200,000 -1,200,000 800,000 800,000 3,600,000 -2,700,000 -2,300,000 -6,200,000 -1,900,000 -1,000,000 -3,100,000 4,100,000 3,500,000 700,000 5,500,000 -3,900,000   -200,000 800,000 400,000 -700,000 -1,600,000 -5,700,000 500,000 -2,400,000 6,000,000 800,000 900,000 -2,600,000 -700,000 8,000,000 -1,500,000 -3,400,000 -8,800,000 1,600,000 -12,800,000 -6,400,000 -2,600,000 1,900,000 -1,000,000 1,400,000 800,000 -900,000 -1,600,000 400,000 1,900,000 -3,900,000 1,900,000 -4,400,000 400,000 
  net change in cash and cash equivalents244,300,000 27,300,000 -2,900,000 -11,600,000 68,800,000 -41,400,000 43,000,000 -18,300,000 -79,300,000 51,600,000 52,900,000 2,400,000 -52,600,000 -3,900,000 -35,600,000 42,200,000 -81,300,000 -9,800,000 9,000,000 -120,000,000 74,500,000 168,100,000 -124,300,000 85,100,000 -19,000,000 42,300,000 45,200,000 -59,300,000 -88,200,000 -14,400,000 77,700,000 17,700,000 1,500,000 33,800,000 8,300,000 -500,300,000 373,300,000 49,400,000 18,800,000 -37,800,000 14,000,000 -4,000,000 -17,200,000 -16,300,000 103,200,000 4,100,000 57,200,000 -82,900,000 83,800,000 -76,900,000 47,300,000 -108,700,000 101,700,000 -19,400,000 -14,600,000 11,300,000 
  cash and cash equivalents, beginning of fiscal year                                                        
  cash and cash equivalents, end of fiscal year                                                        
  supplemental disclosure of cash flow information:                                                        
  cash payments made for interest40,700,000 19,900,000 48,500,000 22,400,000 47,900,000 25,100,000 50,500,000 19,500,000 50,800,000 26,100,000 46,500,000 13,200,000 36,000,000 5,200,000 36,300,000 4,800,000 23,000,000 1,800,000 21,300,000 9,900,000 20,700,000 10,300,000 13,900,000 13,600,000 12,200,000 10,600,000 11,100,000 9,500,000 10,900,000 9,700,000 10,600,000 9,300,000 13,600,000 8,700,000 12,800,000 8,000,000 4,600,000 9,100,000 4,500,000 8,500,000 4,400,000 8,000,000 3,800,000 7,900,000 3,800,000 8,400,000 3,800,000 1,100,000 5,200,000 1,500,000 5,300,000 1,500,000 5,500,000 1,500,000 6,100,000 700,000 
  cash payments made for income taxes, net of refunds67,700,000 42,700,000 54,300,000 115,100,000 67,700,000 30,100,000 72,300,000 70,100,000 86,900,000 45,700,000 13,300,000 34,300,000 9,000,000 11,100,000 11,700,000 45,600,000 27,400,000 10,600,000 14,200,000 45,800,000 27,800,000 12,500,000 19,100,000 41,500,000 36,900,000 21,000,000 31,400,000 30,200,000 25,300,000 27,400,000 46,500,000 78,400,000 25,700,000 12,800,000 19,900,000 55,000,000 33,200,000 10,600,000 48,600,000 30,000,000                 
  non-cash investing and financing activities:                                                        
  accrual of unpaid property, plant, equipment and software                                                        
  accrual of unpaid stock repurchase excise tax                                                        
  write-down of long-lived asset and related charges 1,000,000 2,200,000 100,000  7,300,000 2,000,000 5,600,000  2,200,000                                               
  cash and cash equivalents, beginning of period 304,400,000  252,300,000  224,700,000  274,500,000  476,600,000  273,200,000  263,900,000  271,100,000  727,700,000  324,100,000  347,600,000  266,000,000  320,500,000  241,500,000 
  cash and cash equivalents, end of period 27,300,000 -2,900,000 292,800,000  -41,400,000 43,000,000 234,000,000  51,600,000 52,900,000 227,100,000  -4,000,000 -35,500,000 316,700,000  -9,800,000 9,000,000 356,600,000  168,100,000 -124,300,000 358,300,000  42,300,000 45,100,000 204,700,000  -14,400,000 77,700,000 288,800,000  33,800,000 8,300,000 227,400,000  49,300,000 18,800,000 286,300,000  -4,000,000 -17,200,000 331,300,000  4,100,000 57,200,000 183,100,000  -76,900,000 47,300,000 211,800,000  -19,400,000 -14,600,000 252,800,000 
  accrual of unpaid property, plant and equipment and software 2,300,000 4,000,000 1,100,000  -2,200,000 500,000 2,700,000  -1,200,000 -600,000 2,100,000  -4,900,000 6,700,000 10,200,000  25,600,000 7,500,000 6,400,000  -1,600,000 1,900,000 8,700,000  2,600,000 -100,000 1,900,000  500,000 300,000 1,400,000  6,900,000 600,000                     
  accrual for unpaid stock repurchase excise tax     -400,000 -200,000 800,000                                                 
  current assets and liabilities:                                                        
  non-current assets and liabilities:                                                        
  write-down of long lived assets                                                        
  gain on forward foreign exchange derivative                                                        
  proceeds from asset sales                18,000,000                                     
  settlement of forward foreign exchange derivative                                                        
  net cash flows used in investing activities        -31,300,000 -14,000,000 -21,500,000 -13,600,000 -29,400,000 -27,100,000 -17,500,000 -36,400,000 -2,588,700,000 -21,100,000 -35,200,000 -8,700,000 -13,800,000 -96,700,000 -244,900,000 -86,300,000 -384,400,000 -17,100,000 -15,700,000 -16,300,000 -71,700,000 -92,200,000 -44,200,000 -41,200,000 -46,300,000 -59,600,000 -45,000,000 -508,400,000 -58,700,000 -26,200,000 -33,900,000 -18,100,000 -175,400,000 -50,100,000 -41,700,000 -9,200,000  -72,300,000 -17,500,000 -51,000,000         
  adjustments to reconcile net earnings to net cash flows used in operating activities:                                                        
  increase in accounts receivable            49,300,000    95,900,000    109,200,000    139,100,000   -1,000,000 102,700,000    70,200,000    50,700,000    53,400,000    300,000    -32,600,000        
  increase in other current assets         2,400,000   66,300,000 -21,600,000   -7,900,000 14,000,000 -13,500,000 -22,200,000 3,800,000 16,800,000 -5,100,000 -33,400,000 6,000,000 -1,200,000 -7,500,000 -4,600,000 25,700,000 -27,100,000 11,800,000 -18,000,000 65,600,000 -37,200,000 4,700,000 -27,500,000 39,400,000 -31,400,000 -14,600,000 -5,900,000 32,000,000 -25,700,000   27,700,000 -21,300,000   21,900,000        
  decrease in payables and accrued expenses         127,200,000 11,900,000 -319,300,000   88,200,000 -324,700,000   80,400,000 -220,600,000  132,300,000 35,500,000 -190,500,000  103,300,000 40,900,000 -199,300,000                             
  increase in contract liabilities         13,200,000   -5,900,000 7,800,000   -300,000 6,800,000 7,500,000 -1,600,000 -6,000,000 6,700,000 8,400,000 3,100,000 -3,500,000 5,300,000 17,300,000 -4,000,000                             
  increase in other non-current assets         -113,900,000 -124,400,000 -167,400,000 -181,900,000 -193,500,000 -201,700,000 -119,800,000 -136,900,000 -106,400,000 -116,600,000 -94,600,000 -108,000,000 -77,000,000 -93,300,000 -74,400,000 -47,400,000 -53,600,000 -41,700,000 -45,600,000 -14,300,000 -31,300,000 -13,300,000 -24,600,000 -13,900,000 -19,400,000 -30,300,000 -27,100,000 -15,200,000 -20,500,000 -9,200,000 -14,600,000 -9,300,000 -15,000,000 -8,200,000 -12,800,000 -2,200,000 -19,800,000 -6,500,000 -9,900,000 -13,200,000 -23,600,000 -8,700,000 -15,700,000 -25,100,000 -32,300,000 -36,200,000 -12,900,000 
  increase in other non-current liabilities         69,700,000 55,800,000 13,600,000 -3,100,000 45,300,000 5,900,000 18,100,000 14,700,000 20,500,000 25,600,000 23,200,000 36,800,000 -4,400,000 34,600,000 9,400,000 31,900,000 -900,000 39,200,000 13,600,000 11,600,000 1,600,000 87,000,000 8,100,000 2,500,000 11,400,000 2,000,000 7,300,000 1,500,000 1,800,000 4,900,000 -1,700,000 2,600,000 18,500,000 7,300,000 4,600,000 7,300,000 12,400,000 6,100,000 19,800,000 -20,200,000 7,300,000 2,000,000 4,500,000 3,900,000 700,000 11,000,000 
  decrease in accounts receivable          -4,700,000 115,600,000   -47,400,000 96,600,000   -800,000 101,100,000               -15,100,000 44,400,000   36,700,000   -5,000,000 65,100,000   34,800,000 74,700,000   15,400,000 51,400,000   31,200,000 82,900,000 
  net cash flows used in operating activities          123,100,000 -204,500,000    -135,400,000    -44,200,000    -86,400,000    -95,500,000    -93,300,000    -87,400,000            -5,400,000         
  decrease in other current assets           1,500,000                                23,300,000    900,000   -400,000 500,000     
  decrease in contract liabilities           -17,100,000    -5,800,000                                         
  increase in payables and accrued expenses            126,000,000    142,700,000                                        
  write-down of long-lived assets and related charges             1,400,000    1,100,000 1,900,000 31,700,000                                     
  decrease (increase) in other current assets               1,600,000                                        7,300,000 
  adjustments to reconcile net earnings to net cash flows used in by operating activities:                                                        
  purchase of intellectual property                               -90,000,000                     
  write-down of long-lived assets                     300,000                                   
  decrease (increase) in accounts receivable                       63,800,000        -32,100,000                         
  excess tax benefits from stock-based compensation awards                                -11,600,000 -7,000,000 -1,100,000 -20,900,000  -5,600,000 -4,100,000 -1,400,000                 
  net cash flows used in financing activities                        -34,300,000                -87,000,000 -26,900,000 -22,800,000 -21,600,000  -19,100,000 -23,000,000 -27,300,000         
  increase in accounts payable                            40,000,000    -26,300,000    -600,000    400,000    -8,500,000    13,100,000        
  increase in accrued expenses and other current liabilities                                                        
  increase in deferred revenues                            -79,000,000   37,700,000 -122,800,000   -11,700,000 -88,000,000   2,200,000 -90,300,000 101,200,000 -6,800,000 3,000,000 -85,900,000 89,900,000 600,000 1,200,000 -78,000,000 79,200,000 -600,000 800,000 -89,400,000    
  decrease in accrued expenses and other current liabilities                             58,100,000 24,300,000 -162,500,000  76,400,000 18,300,000 -118,500,000  54,200,000 27,900,000 -96,000,000  52,700,000 21,900,000 -118,300,000  28,500,000 19,400,000 -115,500,000  -6,900,000 24,000,000 -87,900,000  4,000,000 18,900,000 -65,200,000 
  equity method investments                             -1,200,000                           
  proceeds from long-term debt                             70,000,000 190,000,000 145,000,000 125,000,000 120,000,000 110,000,000 597,900,000 105,000,000 40,000,000 65,000,000 200,000,000                
  repayments on long-term debt                             -90,000,000   -185,000,000 -65,000,000   -395,000,000 -40,000,000 -20,000,000 -20,000,000                 
  payment of contingent consideration obligations                                                        
  costs related to amendment of revolving credit facility                                       -1,900,000             
  costs related to issuance of bonds                                -700,000            -4,300,000         
  increase in acquisition related obligations                             3,200,000 4,200,000 2,200,000                         
  obligations related to the purchase of intellectual property                                5,000,000                     
  decrease in accounts payable                              -6,300,000 -3,000,000   6,000,000 -7,900,000   -10,500,000 -3,500,000   -14,900,000 -7,100,000   -14,200,000 -32,200,000   8,800,000 -13,300,000  18,300,000 -200,000 -26,100,000 
  decrease in deferred revenues                                                      8,200,000 -11,000,000 
  equity method investment                               -1,500,000 -1,500,000 -1,500,000 -1,400,000 -1,600,000 -1,600,000 -1,500,000 -1,500,000 -300,000 -2,000,000 -2,000,000 -1,700,000 -1,800,000             
  repayments on senior notes                                                        
  excess tax benefit from stock-based compensation awards                                                        
  payment of contingent consideration liabilities                                   -7,900,000 -200,000 -800,000                 
  acquisition related obligations                                600,000 4,000,000    400,000                   
  unpaid deferred financing costs related to the issuance of bonds                                                        
  amortization of acquired intangibles                                    7,800,000 7,800,000 8,100,000 8,100,000 7,500,000 6,300,000 5,700,000 5,800,000 6,000,000 5,700,000 5,400,000 5,500,000 5,400,000 5,400,000 5,500,000 5,500,000 4,500,000 6,800,000 5,700,000 5,200,000 
  excess tax benefits from the issuance of stock-based compensation awards                                        -19,100,000 -10,800,000 -5,400,000 -5,200,000 -15,100,000 -5,000,000 -1,700,000 -1,000,000 -2,500,000 -800,000 -500,000 -800,000 -2,000,000 -1,800,000 -100,000 
  changes in operating assets and liabilities:                                                        
  excess tax benefit from the issuance of stock-based compensation awards                                                        
  increase in unpaid property, plant, equipment and software included in accrued expenses                                                        
  increase in dividends payable                                    300,000                    
  increase in unpaid deferred financing costs related to the issuance of bonds                                                        
  property, plant and equipment                                     -1,300,000      300,000  1,500,000 100,000    500,000    300,000 
  dividends payable                                      100,000 3,500,000 -200,000 -400,000 100,000 7,200,000 100,000 500,000 3,100,000 -200,000 -300,000 1,600,000    1,300,000 
  purchases of intangibles                                        -8,000,000 -5,800,000 -500,000 -1,400,000 -2,200,000 -3,800,000 -4,300,000 -2,800,000 -6,800,000 -3,400,000 -800,000 -1,700,000 -3,300,000 -1,600,000 -5,500,000 -2,500,000 
  other financing transactions                                                2,500,000 -200,000 -1,000,000 -1,100,000 -1,000,000 -1,200,000 -1,700,000 300,000 
  cash payments made for income taxes                                        40,000,000 3,400,000 35,900,000 32,200,000 48,800,000 9,100,000 41,200,000 51,200,000 20,700,000 41,600,000 16,700,000 39,600,000 9,300,000 7,100,000 21,700,000 33,000,000 
  property, plant and equipment included in accrued expenses                                                        
  repayments of long-term debt                                                        
  proceeds from issuance of bonds, net of discounts                                             399,500,000         
  payments on long-term debt                                                    -30,000,000   
  income from discontinued operations, net of tax                                                        
  impairment of available-for-sale securities and other non-current assets                                                        
  net cash flows from operating activities of continuing operations                                                198,600,000 -1,200,000 89,100,000 -15,600,000 186,700,000 15,800,000 64,800,000 23,300,000 
  sale of available-for-sale securities                                                        
  net cash flows used in investing activities of continuing operations                                                -16,400,000 -16,600,000 -10,900,000 -8,100,000 -7,800,000 -8,800,000 -14,600,000 -79,300,000 
  proceeds from issuance of long-term debt                                                    490,000,000 
  payment on short-term borrowings                                                       -400,000,000 
  payment on long-term debt                                               -400,000,000         
  cost related to issuance of long-term debt                                                    -400,000 -2,500,000 
  net cash flows used in financing activities of continuing operations                                                -97,500,000        
  cash flows from discontinued operations:                                                        
  net cash flows used in discontinued operations                                                        
  cost related to issuance of bonds                                                       
  impairment of available for sale securities and other non-current assets                                                        
  sale of available for sale securities                                                        
  proceeds from short-term borrowings                                                        
  net cash flows from discontinued operations                                                        
  purchases of treasury stock excluded from accrued expenses                                                        
  adjustments to reconcile net earnings to net cash flows from operating activities of continuing operations:                                                        
  income from discontinued operations                                                        
  loss on sale of available-for-sale securities                                                        
  impairment of available-for-sale securities and other noncurrent assets                                                        
  proceeds from sale of available-for-sale securities                                                        
  payments on short-term borrowings                                                       
  cash flows used in financing activities                                                        
  net cash from discontinued operations                                                        
  cash and cash equivalents of discontinued operations, beginning of period                                                        
  less cash and cash equivalents from discontinued operations, end of period                                                        
  cash and cash equivalents of continuing operations, end of period                                                 -76,900,000 47,300,000 211,800,000  -19,400,000 -14,600,000 252,800,000 
  impairment of available-for-sale securities                                                        
  net cash flows from financing activities of continuing operations                                                  -31,300,000 -86,900,000  -27,000,000 -60,400,000 66,900,000 
  cash and cash equivalents of discontinued operations, beginning of fiscal year                                                        
  non-cash operating activities:                                                        
  non-cash obligation assumed from sale of discontinued operations                                                        
  consideration received as part of the sale of discontinued operations                                                        
  loss on sale of available for sale securities                                                        
  impairment of available for sale securities and other noncurrent assets                                                        
  proceeds from sale of available for sale securities                                                        
  impairment of available for sale securities                                                        
  loss (earnings) from discontinued operations, net of tax                                                        
  gain on purchase of senior notes                                                        
  cash and cash equivalents of discontinued operations, end of fiscal year                                                        
  cash and cash equivalents of continuing operations, end of fiscal year                                                        

We provide you with 20 years of cash flow statements for Broadridge Financial Solutions stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Broadridge Financial Solutions stock. Explore the full financial landscape of Broadridge Financial Solutions stock with our expertly curated income statements.

The information provided in this report about Broadridge Financial Solutions stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.